ResearcherInstitute of Chinese Materia MedicaNo recent work listed
Xiaolu Wei
Matched on ORCID iD 0000-0001-9952-3757; OpenAlex author ID A5041997172.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 2, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 1
2020: 2 papers
Papers 2
- Arenobufagin Inhibits the Phosphatidylinositol 3-kinase/Protein Kinase B/Mammalian Target of Rapamycin Pathway and Induces Apoptosis and Autophagy in Pancreati… First author DOI 10.1097/mpa.0000000000001471↗
- Hellebrigenin anti-pancreatic cancer effects based on apoptosis and autophage. First author DOI 10.7717/peerj.9011↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Baolin Bian · 2 shared papers, 2020
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.